The ratio of serum neuron-specific enolase level to admission glasgow coma scale score is associated with diffuse axonal injury in patients with moderate to severe traumatic brain injury
Open Access
- 1 September 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 13, 887818
Abstract
Background: Moderate to severe traumatic brain injury (TBI) is frequently accompanied by diffuse axonal injury (DAI). Considering the low sensitivity of computed tomography (CT) examination for microbleeds and axonal damage, identification of DAI is difficult using conventional diagnostic methods in the acute phase. Neuron-specific enolase (NSE) has been demonstrated to be increased in serum following various types of TBI and is already clinically/commercially available. We conjecture that serum NSE level to admission GCS score ratio (NGR) may be a useful indicator for the early diagnosis of DAI.Methods: This study included 115 patients with moderate-to-severe TBI who underwent NSE measurements within 6 h after injury and brain magnetic resonance imaging (MRI) within 30 days. The positive and negative DAI groups were divided according to MRI findings.Results: Among the 115 patients, 49 (42.6%) were classified into the DAI group and 66 (57.4%) patients into the non-DAI group by clinical MRI. The NGR of patients without DAI was found to be significantly lower than those of patients with DAI (p < 0.0001). NGR presented the largest Pearson r value (r = 0.755, 95% CI 0.664–0.824, p < 0.0001) and high diagnostic accuracy for DAI [area under the curve (AUC) = 0.9493; sensitivity, 90.91%; and specificity, 85.71%]. Patients with TBI presenting with higher NGR were more likely to suffer an unfavorable neurological outcome [6-month extended Glasgow Outcome Scale (GOSE) 1–4].Conclusions: The NGR on admission could serve as an independent predictor of DAI with moderate-to-severe TBI.Keywords
Funding Information
- Tianjin Research Program of Application Foundation and Advanced Technology of China (19YFZCSY00650)
This publication has 39 references indexed in Scilit:
- Prognostic Value of Serum Levels of S100 Calcium-Binding Protein B, Neuron-Specific Enolase, and Interleukin-6 in Pediatric Patients with Traumatic Brain InjuryWorld Neurosurgery, 2018
- Serial measurement of S100B and NSE in pediatric traumatic brain injuryChild's Nervous System, 2018
- Metabolomics and Biomarker Discovery in Traumatic Brain InjuryJournal of Neurotrauma, 2018
- Prognosis of diffuse axonal injury with traumatic brain injuryJournal of Trauma and Acute Care Surgery, 2018
- Elevated Serum Protein S100B and Neuron Specific Enolase Values as Predictors of Early Neurological Outcome after Traumatic Brain InjuryJournal of Medical Biochemistry, 2017
- Serum Neurofilament Light Protein as a Marker for Diffuse Axonal Injury: Results from a Case Series StudyJournal of Neurotrauma, 2017
- Progress of Research on Diffuse Axonal Injury after Traumatic Brain InjuryNeural Plasticity, 2016
- Diffuse Axonal Injury in Patients With Head Injuries: An Epidemiologic and Prognosis Study of 124 CasesJournal of Trauma: Injury, Infection & Critical Care, 2011
- Prevalence and impact of diffuse axonal injury in patients with moderate and severe head injury: a cohort study of early magnetic resonance imaging findings and 1-year outcomeJournal of Neurosurgery, 2010
- Diagnostic value of S100B and neuron-specific enolase in mild pediatric traumatic brain injuryJournal of neurosurgery. Pediatrics, 2009